Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Europe Sun.
Press releases published on May 16, 2025
Best Crypto Casinos USA: JACKBIT Is Ranked #1 Top Bitcoin Online Casino With Exclusive Bonuses & Fast Payouts!
GlobeNewswire
·
May 16, 2025
JERSEY CITY, N.J., May 16, 2025 (GLOBE NEWSWIRE) -- The crypto casino industry is booming, gaining massive traction in the global gaming scene with its promise of secure, anonymous, and swift transactions. As players across the USA embrace this trend, the …
Huma Announces Partnership with Eckuity Capital to Accelerate M&A and Acquires Aluna
GlobeNewswire
·
May 16, 2025
New York, May 16, 2025 (GLOBE NEWSWIRE) -- Huma Therapeutics (“Huma”), the global healthcare AI leader accelerating digital transformation across care and research, today announced two major milestones: A global partnership agreement with Eckuity Capital …
BlueSphere Bio Appoints Alan Korman, Ph.D. as Chief Scientific Officer
GlobeNewswire
·
May 16, 2025
PITTSBURGH, May 16, 2025 (GLOBE NEWSWIRE) -- BlueSphere Bio, a clinical stage drug development company focused on novel T cell based therapies, today announced the appointment of Alan Korman, Ph.D., as Chief Scientific Officer. Dr. Korman brings extensive …
Stellar (XLM) & Ripple (XRP) Investors Flock To Xrpturbo For Stable Staking Returns, Here’s Why
GlobeNewswire
·
May 16, 2025
TALLINN, Estonia, May 16, 2025 (GLOBE NEWSWIRE) -- In a crypto market characterized by high volatility, investors in Stellar (XLM) and Ripple (XRP) are increasingly turning to Xrpturbo, an innovative DeFi and AI-driven launchpad built on the XRP Ledger, to …
Medicines for Poland: Europa steht vor einer kritischen Entscheidung über Arzneimittel und Marktreformen
GlobeNewswire
·
May 16, 2025
Warschau, Polen, May 16, 2025 (GLOBE NEWSWIRE) -- Die Mitgliedstaaten stehen kurz vor dem Abschluss der Diskussionen über die EU-Arzneimittelreform, mit der erschwingliche Medikamente sichergestellt und die Produktion in Europa gefördert werden sollen. …
Medicines for Poland : l’Europe fait face à un dilemme majeur sur la question des médicaments et de la réforme du marché
GlobeNewswire
·
May 16, 2025
VARSOVIE, Pologne, 16 mai 2025 (GLOBE NEWSWIRE) -- Les États membres s’apprêtent à conclure les discussions sur la réforme pharmaceutique de l’UE afin de garantir des médicaments abordables et de soutenir la production de l’UE au sein de l’Europe. Cela …
Medicines for Poland : l'Europe face à un choix crucial en matière de médicaments et de réforme du marché
GlobeNewswire
·
May 16, 2025
VARSOVIE, Pologne, 16 mai 2025 (GLOBE NEWSWIRE) -- Les États membres approchent de la fin des discussions sur la réforme pharmaceutique de l'UE visant à garantir des médicaments abordables et à soutenir la fabrication de médicaments de l'UE en Europe. Cela …
GRI Bio to Present at A.G.P.'s Annual Healthcare Company Showcase
GlobeNewswire
·
May 16, 2025
Live webcast fireside chat with Marc Hertz, PhD, Chief Executive Officer on Wednesday, May 21st at 2:40 PM ET LA JOLLA, CA, May 16, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an …
Svitlana Buriak wins the 11th IBFD Frans Vanistendael Award
GlobeNewswire
·
May 16, 2025
Amsterdam, May 16, 2025 (GLOBE NEWSWIRE) -- At a ceremony this afternoon, Svitlana Buriak was announced as the winner of the award for her publication titled "International Taxation of Global Value Networks", published by IBFD Doctoral Series. The ongoing …
BON Announces The Launch Of Its Postbiotic Hypoglycemic Patented Ingredient Product Series And Its Cooperation Agreement
GlobeNewswire
·
May 16, 2025
XI’AN, China, May 16, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced an exclusive cooperation agreement with …
FRO – Invitation to Q1 2025 Results Conference Call and Webcast
GlobeNewswire
·
May 16, 2025
Frontline plc.’s preliminary first quarter 2025 results will be released on Friday May 23, 2025, and a webcast and conference call will be held at 3:00 p.m. CET (9:00 a.m. U.S. Eastern Time). The results presentation will be available for download from the …
Medicines for Poland: Europe Faces a Critical Choice on Medicines and Market Reform
GlobeNewswire
·
May 16, 2025
WARSAW, Poland, May 16, 2025 (GLOBE NEWSWIRE) -- Member States are nearing the end of discussions on EU pharmaceutical reform to ensure affordable medicines and support EU manufacturing in Europe. This will enhance the Union’s strategic resilience and …
Rio Silver Receives Conditional Approval for Acquisition of Mamaniña Exploraciones S.A.C.
GlobeNewswire
·
May 16, 2025
VANCOUVER, British Columbia, May 16, 2025 (GLOBE NEWSWIRE) -- Rio Silver Inc. (the “Company”) (TSX.V: RYO) (OTC: RYOOF) announces that, further to its announcement on March 26, 2025, it has received from the TSX Venture Exchange (the “Exchange”) …
Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study
GlobeNewswire
·
May 16, 2025
Company intends to provide an interim read out by the end of summer 2025 Top-line results anticipated in Q4 2025; study on track to support U.S. pivotal trial initiation in 2026 BERKELEY, Calif. and MAINZ, Germany, May 16, 2025 (GLOBE NEWSWIRE) -- Mainz …
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 16, 2025
SOUTH SAN FRANCISCO, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …
Vivex Biologics, Inc. Executive Chair Nominated for Ernst & Young LLP Entrepreneur of the Year® 2025 Florida Award
GlobeNewswire
·
May 16, 2025
MIAMI, May 16, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced the company’s Executive Chairman, John A. McCallum, has been selected as a finalist in the prestigious Ernst …
Replimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and Upcoming Investor Day
GlobeNewswire
·
May 16, 2025
WOBURN, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that it will host a conference call on Thursday, May …
Spectral Medical to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference
GlobeNewswire
·
May 16, 2025
TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that management will participate in a …
NexGold Infill Drilling Intersects New Zones of Gold Mineralization at the Goldboro Gold Project
GlobeNewswire
·
May 16, 2025
TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to provide an update on its ongoing 25,000 metre diamond drill program initially announced on January 22, 2025 at the Company’ …
Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting
GlobeNewswire
·
May 16, 2025
Company Urges Stockholders to Vote ‘FOR’ Reverse Stock Split Proposal at Upcoming Annual Meeting to Avoid Nasdaq Delisting Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Support Proposal #2 SOUTH SAN FRANCISCO, Calif., May 16, 2025 (GLOBE …